NASDAQ: DHAIDih Holding Us Inc Stock
$0.15+0.01 (+7.14%)
Updated Apr 22, 2025
DHAI Price
$0.15
Fair Value Price
N/A
Market Cap
$7.20M
52 Week Low
$0.12
52 Week High
$3.67
P/E
N/A
P/B
-0.19x
P/S
0.71x
PEG
N/A
Dividend Yield
N/A
Revenue
$67.57M
Earnings
-$8.56M
Gross Margin
48.6%
Operating Margin
-9.46%
Profit Margin
-12.7%
Debt to Equity
-1.84
Operating Cash Flow
$2M
Beta
0.38
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
DHAI Overview
Aurora Technology Acquisition Corp. is a "blank check" company formed to effect mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or related business combinations. It targets tech companies (artificial intelligence, blockchain, quantum computing, electric vehicles) in the U.S. and Asia. Sponsored by ATAC Sponsor LLC, Aurora Technology was incorporated in 2021 and is based in San Francisco, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DHAI's potential to beat the market
- DHAI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
B
DHAI
RankedUnranked of 103
RankedUnranked of 103
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.49 | A | |
| $22.99 | A | |
| $13.80 | A |
Be the first to know about important DHAI news, forecast changes, insider trades & much more!
DHAI News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DHAI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DHAI's Earnings (EBIT) of -$6.40M are insufficient to safely cover interest payments on company debt ($15.03M)
Interest Coverage Financials
DHAI's profit margin has decreased (-17.6%) in the last year from (4.9%) to (-12.7%)
Profit Margin Growth Financials
DHAI's short-term liabilities ($47.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more DHAI due diligence checks available for Premium users.
Valuation
DHAI fair value
Fair Value of DHAI stock based on Discounted Cash Flow (DCF)
Price
$0.15
Fair Value
$0.68
Undervalued by
77.86%
DHAI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
41.11x
Market
28.14x
DHAI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.19x
Industry
3.8x
DHAI's financial health
Profit margin
Revenue
$15.1M
Net Income
-$3.7M
Profit Margin
-24.7%
DHAI's Earnings (EBIT) of -$6.40M... subscribe to Premium to read more.
Interest Coverage Financials
DHAI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$31.8M
Liabilities
$69.7M
Debt to equity
-1.84
DHAI's short-term liabilities ($47.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DHAI's short-term assets ($24.16M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DHAI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DHAI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$686.0k
Investing
-$21.0k
Financing
-$1.6M
DHAI's operating cash flow ($2.43M)... subscribe to Premium to read more.
Debt Coverage Financials
DHAI vs Medical Device Stocks
Dih Holding Us Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.